Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Oncology granted stock options to five new employees to purchase an aggregate of 154,700 shares of common stock, effective May 1, 2026. The options were approved by the Compensation Committee under the Company's 2022 Inducement Plan with an exercise price of $14.32 per share, equal to the closing price on the grant date.
Key figures
- Shares granted
- 154700
- Employees granted
- 5
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.